Exlr Pharmaceuticals Private Limited
About Exlr Pharmaceuticals Private Limited
Data last updated:
Exlr Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 22 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2018PTC123236. Its GSTIN is 36AAECE9879L1ZR (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maheswari Panuganti and Venkataravikanth Panuganti.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at # Flat No: 101 Poojitha Residency Mithilanagar Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.68 Lakh, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹1,049 (net margin 0.4%) and EBITDA of ₹14,660 (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 12% over five years.
Company details
Contact details
Exlr Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address# Flat No: 101 Poojitha Residency Mithilanagar Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Exlr Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Exlr Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Exlr Pharmaceuticals Private Limited, buy the company report.
Financials of Exlr Pharmaceuticals Private Limited
FY 2024 filings availableExlr Pharmaceuticals Private Limited reported revenue of ₹2.68 Lakh (up 84% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 84% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,660 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,049 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exlr Pharmaceuticals Private Limited, buy the company report.
Board of directors of Exlr Pharmaceuticals Private Limited
Exlr Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maheswari Panuganti Also directs: C-Cayr Pharmaceuticals Private Limited | Director | 24 Sep 2019 | 7 Years 0 Months | Current |
| Venkataravikanth Panuganti | Director | 22 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Exlr Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viashvi Pharmaceuticals Private Limited | ₹2.72 Lakh (FY 2024) | -67.0% | Amethi, Uttar Pradesh, India | |||
| Mbix Pharmaceuticals Private Limited | ₹2.71 Lakh (FY 2021) | 144.0% | Patna, Bihar, India | |||
| Reverie Pharmaceuticals Private Limited | ₹2.7 Lakh (FY 2025) | -33.0% | Ahmedabad, Gujarat, India | |||
| Exlr Pharmaceuticals Private Limitedthis company | ₹2.68 Lakh (FY 2024) | ₹1,049 | 0.4% | 84.0% | Hyderabad, Telangana, India | |
| Griffix Pharmaceuticals Private Limited | ₹2.63 Lakh (FY 2023) | -47.0% | New Delhi, Delhi, India | |||
| Cerise Pharmaceuticals Private Limited | ₹2.62 Lakh (FY 2018) | Palgarh, Maharashtra, India |
To see the full peer comparison of Exlr Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Exlr Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exlr Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Exlr Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECE9879L1ZR | Telangana | Active | 31 May 2018 |
To see the full GST registrations and return filing status of Exlr Pharmaceuticals Private Limited, buy the company report.
Recent activity
Exlr Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Maheswari Panuganti was appointed as Director on 24 Sep 2019.
Frequently asked questions
Exlr Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 22 March 2018 (8+ years old) and is registered under CIN U24304TG2018PTC123236.
Exlr Pharmaceuticals has 2 current directors:
- Maheswari Panuganti - Director
- Venkataravikanth Panuganti - Director
The latest financial statements of Exlr Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Exlr Pharmaceuticals is 36AAECE9879L1ZR, registered in Telangana.
The CIN (Corporate Identification Number) of Exlr Pharmaceuticals is U24304TG2018PTC123236. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exlr Pharmaceuticals was incorporated on 22 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Exlr Pharmaceuticals by revenue are Viashvi Pharmaceuticals Private Limited, Mbix Pharmaceuticals Private Limited, Reverie Pharmaceuticals Private Limited, Griffix Pharmaceuticals Private Limited, Cerise Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Maheswari Panuganti was appointed as Director on 24 Sep 2019. Sudharani Lingapogu ceased to be Director on 24 Sep 2019. Venkataravikanth Panuganti was appointed as Director on 22 Mar 2018.
The registered office of Exlr Pharmaceuticals is at # Flat No: 101 Poojitha Residency Mithilanagar Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
Exlr Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Exlr Pharmaceuticals can be reached at its registered office: # Flat No: 101 Poojitha Residency Mithilanagar Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.